5 completed. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 1 | Completed 1 |
Follow Developmental Disabilities: new trials by email Literature Review of Developmental Disabilities trials Research Report on Developmental Disabilities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Propranolol for Challenging Behaviors in Autism Propranolol - Autism Spectrum Disorder, Developmental Disability | Phase 2 | Completed | Rutgers, The State University of New Jersey | 8 | 2021-02-11 | 2025-06-04 |
| Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders Bioactive Factors, Produced by M2 Type Macrophages (M2-BFs). - Language Delay, Language; Developmental Disorder, Expressive | Phase 1 / Phase 2 | Completed | Russian Academy of Medical Sciences | 14 | 2020-02-01 | 2022-05-02 |
| A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome BPN14770, Placebo - Fragile X Syndrome, FXS | Phase 2 | Completed | Tetra Discovery Partners | 30 | 2018-07-09 | 2024-12-19 |
| Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders Riluzole, Placebo - Obsessive-Compulsive Disorder, Autism Spectrum Disorder | Phase 2 | Completed | National Institute of Mental Health (NIMH) | 78 | 2005-08-01 | 2014-07-15 |
| Effects of Intensity of Early Communication Intervention Milieu Communication Teaching - Communication Disorders, Developmental Disabilities | Phase 2 | Completed | University of Kansas | 70 | 2005-07-01 | 2010-11-01 |
Autism Spectrum Disorder (4) · Autistic Disorder (2) · Aggression (1) · Asperger Syndrome (1) · Attention Deficit Disorder with Hyperactivity (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cognition Disorders (1) · Cognitive Dysfunction (1) · Communication Disorders (1) · Fragile X Syndrome (1) · Genetic Diseases, Inborn (1) · Language (1) · Language Development Disorders (1)
Neurodevelopmental Disorders (5) · Child Development Disorders, Pervasive (4) · Mental Disorders (4) · Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Behavior (2) · Communication Disorders (2) · Nervous System Diseases (2) · Aberrant Motor Behavior in Dementia (1) · Anxiety Disorders (1) · Attention Deficit and Disruptive Behavior Disorders (1) · Behavioral Symptoms (1) · Chromosome Disorders (1)
BPN14770 (1) · Propranolol (1) · Riluzole (1)
National Institute of Mental Health (NIMH) (1) · Russian Academy of Medical Sciences (1) · Rutgers, The State University of New Jersey (1) · Tetra Discovery Partners (1) · University of Kansas (1)
United States (4) · Russia (1)
Alexander A Ostanin, MD, PhD (1) · Barbie Zimmerman-Bier, M.D. (1) · Elena R Chernykh, MD, PhD (1) · Steven F. Warren, Ph.D. (1) · Susan E Swedo, MD (1)
PMID 18315448, PMID 24356715, PMID 33927413
R01DC007660 (1)